Literature DB >> 15102969

ACTH-induced improvement in the nephrotic syndrome in patients with a variety of diagnoses.

Anna-Lena Berg1, Margret Arnadottir.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15102969     DOI： 10.1093/ndt/gfh110

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  35 in total

Review 1.  The renaissance of corticotropin therapy in proteinuric nephropathies.

Authors:  Rujun Gong
Journal:  Nat Rev Nephrol       Date:  2011-12-06       Impact factor: 28.314

2.  Melanocortin 1 receptor agonists reduce proteinuria.

Authors:  Annika Lindskog; Kerstin Ebefors; Martin E Johansson; Bergur Stefánsson; Anna Granqvist; Margret Arnadottir; Anna-Lena Berg; Jenny Nyström; Börje Haraldsson
Journal:  J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 10.121

3.  Balancing cancer risk and efficacy of using cyclophosphamide to treat idiopathic membranous nephropathy.

Authors:  Sana Khan; W Kline Bolton
Journal:  Clin J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 8.237

Review 4.  Membranous nephropathy: the start of a paradigm shift.

Authors:  Sandra M S Herrmann; Sanjeev Sethi; Fernando C Fervenza
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-03       Impact factor: 2.894

Review 5.  Leveraging melanocortin pathways to treat glomerular diseases.

Authors:  Rujun Gong
Journal:  Adv Chronic Kidney Dis       Date:  2014-03       Impact factor: 3.620

6.  Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.

Authors:  Jonathan Hogan; Andrew S Bomback; Kshama Mehta; Pietro A Canetta; Maya K Rao; Gerald B Appel; Jai Radhakrishnan; Richard A Lafayette
Journal:  Clin J Am Soc Nephrol       Date:  2013-09-05       Impact factor: 8.237

Review 7.  Treatment of idiopathic membranous nephropathy.

Authors:  Julia M Hofstra; Fernando C Fervenza; Jack F M Wetzels
Journal:  Nat Rev Nephrol       Date:  2013-07-02       Impact factor: 28.314

8.  Adrenocorticotropic Hormone for Childhood Nephrotic Syndrome: The ATLANTIS Randomized Trial.

Authors:  Chia-Shi Wang; Curtis Travers; Courtney McCracken; Traci Leong; Rasheed Gbadegesin; Alejandro Quiroga; Mark R Benfield; Guillermo Hidalgo; Tarak Srivastava; Megan Lo; Ora Yadin; Robert Mathias; Carlos E Araya; Myda Khalid; Alvaro Orjuela; Joshua Zaritsky; Samhar Al-Akash; Margret Kamel; Larry A Greenbaum
Journal:  Clin J Am Soc Nephrol       Date:  2018-11-15       Impact factor: 8.237

Review 9.  Controversies in the treatment of idiopathic membranous nephropathy.

Authors:  Meryl Waldman; Howard A Austin
Journal:  Nat Rev Nephrol       Date:  2009-07-07       Impact factor: 28.314

Review 10.  Idiopathic membranous nephropathy: management strategies.

Authors:  Marco Quaglia; Piero Stratta
Journal:  Drugs       Date:  2009-07-09       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.